Our partner created a pipeline of disease-modifying therapeutics with the potential to safely and effectively target the root cause of serious genetic neuromuscular and neurological disorders.

This critical hire led and managed the analytical development needs for the pipeline, ensuring effective communication and collaboration with internal teams and CMO partners across the US, Asia, and Europe. They oversaw analytical-related regulatory reports, submissions, and responses, ensuring compliance with all applicable guidelines.